Pacific Biosciences of California Financial Flexibility Index
Pacific Biosciences of California financial flexibility index. Pacific Biosciences of California (PACB) has a Financial Flexibility Index of -0.10x as of June 2026. Free cash flow of $-75.68 Million (operating CF $-80.27 Million minus capex $4.60 Million) represents 0% of total liabilities ($785.06 Million). See Pacific Biosciences of California free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Pacific Biosciences of California (2008–2025)
Financial flexibility index of Pacific Biosciences of California from 2008 to 2025. Historical Financial Flexibility Index trend for Pacific Biosciences of California across 18 annual periods. Check cash flow quality index of Pacific Biosciences of California to evaluate the quality of earnings relative to operating cash generation.
Pacific Biosciences of California Financial Flexibility Index by Year (2008–2025)
Pacific Biosciences of California financial flexibility index by year from 2008 to 2025. Year-by-year free cash flow to debt coverage for Pacific Biosciences of California. For the full cash flow conversion analysis, see PACB cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.14x | $-108.50 Million | $-111.21 Million | $778.73 Million | ▲ +47.5% |
| 2024 | -0.27x | $-199.87 Million | $-206.06 Million | $753.85 Million | ▼ -7.5% |
| 2023 | -0.25x | $-257.70 Million | $-266.55 Million | $1.04 Billion | ▼ -20.6% |
| 2022 | -0.20x | $-246.28 Million | $-263.21 Million | $1.20 Billion | ▼ -136.3% |
| 2021 | -0.09x | $-105.25 Million | $-111.18 Million | $1.22 Billion | ▼ -133.1% |
| 2020 | 0.26x | $20.54 Million | $19.50 Million | $78.49 Million | ▲ +132.3% |
| 2019 | -0.81x | $-75.48 Million | $-78.31 Million | $93.07 Million | ▲ +29.4% |
| 2018 | -1.15x | $-64.58 Million | $-66.43 Million | $56.21 Million | ▼ -16.7% |
| 2017 | -0.98x | $-57.09 Million | $-67.52 Million | $57.98 Million | ▲ +12.3% |
| 2016 | -1.12x | $-59.72 Million | $-67.93 Million | $53.22 Million | ▼ -44.0% |
| 2015 | -0.78x | $-44.88 Million | $-47.89 Million | $57.57 Million | ▼ -8.8% |
| 2014 | -0.72x | $-49.86 Million | $-51.47 Million | $69.57 Million | ▼ -66.0% |
| 2013 | -0.43x | $-28.92 Million | $-29.83 Million | $67.00 Million | ▲ +88.3% |
| 2012 | -3.70x | $-75.12 Million | $-76.82 Million | $20.30 Million | ▼ -6.1% |
| 2011 | -3.49x | $-93.69 Million | $-102.97 Million | $26.85 Million | ▲ +22.6% |
| 2010 | -4.51x | $-116.74 Million | $-122.00 Million | $25.88 Million | ▼ -1701.5% |
| 2009 | -0.25x | $-69.66 Million | $-74.84 Million | $278.22 Million | ▼ -58.6% |
| 2008 | -0.16x | $-32.60 Million | $-38.30 Million | $206.50 Million | — |